IL6 and cancer: Several studies have shown associations between elevated plasma levels of pro-inflammatory cytokines [i.e., tumour necrosis factor Alpha (TNFα) and interleukin 6 (IL6)] and increased levels of fatigue, pain, sleep disturbance, and depressive symptoms in cancer survivors, which may underly the etiopathogenesis [1].